925641-63-0Relevant articles and documents
HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER
-
Paragraph 00105, (2020/10/20)
Compounds which are thiazole and triazole derivatives are disclosed, including compounds of the following genus: Formula I. The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are useful in the treatment of a variety of disorders, including a fibrosis or a fibrotic disease, such as renal fibrosis.